$ 180 million
Completed
18/2/2019
Rajeeb Gurung - Researcher
Switzerland
Financing
Banking and finance
Corporate and M&A
Pharmaceuticals and life sciences
Party: Arvelle Therapeutics (Investment target)
Party: NovaQuest (Investor)
Party: SK Biopharmaceuticals (Seller)
Party: SK Biopharmaceuticals (Seller)